| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
137,858,000 |
| Market
Cap: |
849.21(M) |
| Last
Volume: |
3,159,761 |
Avg
Vol: |
1,451,479 |
| 52
Week Range: |
$6.16 - $6.16 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Achison engages only in internet advertising through www.dazhong368.com in the New York area.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Deshpande Milind |
President and CEO |
• • – |
2015-01-21 |
4 |
OE |
$3.02 |
$302,000 |
D/D |
100,000 |
100,000 |
|
- |
|
| Ra Capital Biotech Fund Lp |
Former 10% Owner, See FN(5)(6) |
– – – |
2014-09-30 |
4 |
S |
$10.02 |
$11,163,819 |
I/I |
(1,111,000) |
6,700,000 |
|
- |
|
| Ra Capital Biotech Fund Lp |
Former 10% Owner, See FN(5)(6) |
– – – |
2014-09-29 |
4 |
S |
$10.96 |
$2,423,264 |
I/I |
(221,014) |
7,811,000 |
|
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2014-09-26 |
4 |
S |
$10.96 |
$7,424,790 |
I/I |
(670,000) |
8,032,014 |
|
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2014-09-25 |
4 |
S |
$11.01 |
$5,501,745 |
I/I |
(497,986) |
8,702,014 |
|
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2014-09-24 |
4 |
S |
$11.24 |
$13,574,954 |
I/I |
(1,204,929) |
9,200,000 |
|
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2014-09-23 |
4 |
S |
$11.02 |
$10,909,010 |
I/I |
(984,522) |
10,404,929 |
|
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2014-09-22 |
4 |
S |
$11.08 |
$4,940,414 |
I/I |
(445,689) |
11,389,451 |
|
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2014-09-19 |
4 |
S |
$11.50 |
$13,450,957 |
I/I |
(1,164,860) |
11,835,140 |
|
- |
|
| Kolchinsky Peter |
10% Owner |
– – • |
2014-09-11 |
4 |
S |
$12.31 |
$14,605,225 |
I/I |
(1,181,912) |
13,000,000 |
|
- |
|
| Kolchinsky Peter |
10% Owner |
– – • |
2014-09-10 |
4 |
S |
$12.61 |
$2,147,483,647 |
I/I |
(522,450) |
14,181,912 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2014-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
100,995 |
260,891 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2014-09-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,200,000) |
4,572,968 |
|
- |
|
| Kolchinsky Peter |
10% Owner |
– – • |
2014-09-02 |
4 |
S |
$11.93 |
$3,160,329 |
I/I |
(262,807) |
14,704,362 |
|
- |
|
| Kolchinsky Peter |
10% Owner |
– – • |
2014-08-29 |
4 |
S |
$11.40 |
$4,551,768 |
I/I |
(398,845) |
14,967,169 |
|
- |
|
| Kolchinsky Peter |
10% Owner |
– – • |
2014-08-28 |
4 |
S |
$11.51 |
$1,999,372 |
I/I |
(173,641) |
15,366,014 |
|
- |
|
| Kolchinsky Peter |
10% Owner |
– – • |
2014-08-27 |
4 |
S |
$11.48 |
$3,096,776 |
I/I |
(267,089) |
15,539,655 |
|
- |
|
| Kolchinsky Peter |
10% Owner |
– – • |
2014-08-26 |
4 |
S |
$11.13 |
$23,981,551 |
I/I |
(2,112,867) |
15,806,744 |
|
- |
|
| Kolchinsky Peter |
10% Owner |
– – • |
2014-08-25 |
4 |
S |
$10.94 |
$3,632,282 |
I/I |
(331,396) |
17,919,611 |
|
- |
|
| Truitt Joseph |
EVP, Chief Commercial Officer |
• – – |
2014-08-25 |
4 |
S |
$10.82 |
$270,500 |
D/D |
(25,000) |
0 |
|
- |
|
| Truitt Joseph |
EVP, Chief Commercial Officer |
• – – |
2014-08-25 |
4 |
OE |
$0.82 |
$20,500 |
D/D |
25,000 |
25,000 |
|
- |
|
| Deshpande Milind |
President and CEO |
• • – |
2014-08-18 |
4 |
S |
$10.00 |
$2,166,240 |
D/D |
(216,624) |
0 |
|
- |
|
| Deshpande Milind |
President and CEO |
• • – |
2014-08-18 |
4 |
OE |
$1.05 |
$664,262 |
D/D |
216,624 |
124,424 |
|
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2014-08-18 |
4 |
S |
$9.51 |
$19,279,545 |
I/I |
(1,993,978) |
18,251,007 |
|
- |
|
| Ra Capital Biotech Fund Lp |
10% Owner |
– – • |
2014-08-15 |
4 |
S |
$9.34 |
$21,069,423 |
I/I |
(2,241,022) |
20,244,985 |
|
- |
|
95 Records found
|
|
Page 3 of 4 |
|
|
